Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

257
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
257
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

1.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

299
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

509
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
509
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

395
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
395
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma.

Neuro-oncology·2025
Same author

Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology.

Neuro-oncology·2025
Same author

Biochemical characterization and activity enhancement of a GH13 thermostable oligo-α-1,6-glucosidase from Geobacillus stearothermophilus.

International journal of biological macromolecules·2025
Same author

Point mutations enhance catalytic efficiency of Geobacillus stearothermophilus α-glucosidase: A biochemical characterization study.

International journal of biological macromolecules·2025
Same author

HOX gene dysregulation in glioblastoma: a narrative review of current advances.

Discover oncology·2025
Same author

Editorial: Multi-omic approaches decipher the pathogenesis of nervous system diseases and identify potential therapeutic drugs.

Frontiers in genetics·2024

Related Experiment Video

Updated: May 7, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K

A novel recommender framework with chatbot to stratify heart attack risk.

Tursun Wali1, Almat Bolatbekov1, Ehesan Maimaitijiang2

  • 1Department of Engineering in the Faculty of Science, Thompson Rivers University, 805 TRU Way, Kamloops, BC V2C 0C8 Canada.

Discover Medicine
|January 6, 2025
PubMed
Summary

This study introduces an explainable artificial intelligence system for heart attack risk prediction. The system uses machine learning and a large language model to provide transparent risk assessments and personalized health advice, improving patient management.

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.1K

Related Experiment Videos

Last Updated: May 7, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.4K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.1K

Area of Science:

  • Cardiovascular disease research
  • Artificial intelligence in healthcare
  • Machine learning for risk prediction

Background:

  • Cardiovascular diseases are a leading cause of death, necessitating early detection and intervention.
  • Machine learning models show promise for identifying heart attack risk, but often lack transparency.
  • Understanding specific risk factors and their associations is crucial for clinical diagnosis.

Purpose of the Study:

  • To develop an explainable artificial intelligence (XAI) system for heart attack prediction and risk stratification.
  • To enhance transparency in machine learning-based cardiovascular risk assessment.
  • To integrate a conversational AI for patient consultation and support.

Main Methods:

  • Applied the CatBoost classifier for initial heart attack risk prediction.
  • Utilized SHAP (SHapley Additive exPlanations) for transparently explaining model predictions.
  • Integrated the BioMistral Large Language Model (LLM) for a digital doctor chatbot functionality.
  • Developed a Django-based web application with Google Maps API integration.

Main Results:

  • Achieved high accuracy in predicting patient risk levels, with an average AUC of 0.88.
  • The system provides both group-based and patient-specific explanations for risk classifications.
  • The integrated LLM chatbot offers consultation, answers user questions, and provides hospital location services.
  • The system demonstrates improved patient management and potential for lowering heart attack risk.

Conclusions:

  • The developed XAI recommender system offers accurate and transparent heart attack risk prediction.
  • The system enhances patient understanding and engagement in managing cardiovascular health.
  • The combination of predictive modeling, explainability, and conversational AI represents a significant advancement in digital health tools.
  • Timely intervention facilitated by such systems can aid in avoiding subsequent disabilities from cardiovascular events.